These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2424286

  • 1. Targets and markers of selective action of tiazofurin.
    Weber G, Natsumeda Y, Pillwein K.
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [Abstract] [Full Text] [Related]

  • 2. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G, Natsumeda Y, Lui MS, Faderan MA, Liepnieks JJ, Elliott WL.
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [Abstract] [Full Text] [Related]

  • 3. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS, Faderan MA, Liepnieks JJ, Natsumeda Y, Olah E, Jayaram HN, Weber G.
    J Biol Chem; 1984 Apr 25; 259(8):5078-82. PubMed ID: 6143752
    [Abstract] [Full Text] [Related]

  • 4. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN.
    Adv Enzyme Regul; 1985 Apr 25; 24():67-89. PubMed ID: 3835825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G, Jayaram HN, Lapis E, Natsumeda Y, Yamada Y, Yamaji Y, Tricot GJ, Hoffman R.
    Adv Enzyme Regul; 1988 Apr 25; 27():405-33. PubMed ID: 2907968
    [Abstract] [Full Text] [Related]

  • 7. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y, Natsumeda Y, Weber G.
    Biochemistry; 1988 Mar 22; 27(6):2193-6. PubMed ID: 2897864
    [Abstract] [Full Text] [Related]

  • 8. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin.
    Weber G, Lui MS, Jayaram HN, Pillwein K, Natsumeda Y, Faderan MA, Reardon MA.
    Adv Enzyme Regul; 1985 Mar 22; 23():81-99. PubMed ID: 3907307
    [Abstract] [Full Text] [Related]

  • 9. Tiazofurin: molecular and clinical action.
    Weber G, Prajda N, Abonyi M, Look KY, Tricot G.
    Anticancer Res; 1996 Mar 22; 16(6A):3313-22. PubMed ID: 9042306
    [Abstract] [Full Text] [Related]

  • 10. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y, Natsumeda Y, Yamaji Y, Jayaram HN, Tricot GJ, Hoffman R, Weber G.
    Leuk Res; 1989 Mar 22; 13(2):179-84. PubMed ID: 2564451
    [Abstract] [Full Text] [Related]

  • 11. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K, Sreenath A, Hao Z, Paull KD, Szekeres T, Cooney DA, Krohn K, Jayaram HN.
    Biochem Pharmacol; 1994 Oct 07; 48(7):1413-9. PubMed ID: 7945441
    [Abstract] [Full Text] [Related]

  • 12. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N, Hata Y, Abonyi M, Singhal RL, Weber G.
    Cancer Res; 1993 Dec 15; 53(24):5982-6. PubMed ID: 7903199
    [Abstract] [Full Text] [Related]

  • 13. Tiazofurin-induced selective depression of NAD content in hepatoma 3924A.
    Liepnieks JJ, Faderan MA, Lui MS, Weber G.
    Biochem Biophys Res Commun; 1984 Jul 18; 122(1):345-9. PubMed ID: 6743337
    [Abstract] [Full Text] [Related]

  • 14. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G, Yamaji Y, Olah E, Natsumeda Y, Jayaram HN, Lapis E, Zhen WN, Prajda N, Hoffman R, Tricot GJ.
    Adv Enzyme Regul; 1989 Jul 18; 28():335-56. PubMed ID: 2576178
    [Abstract] [Full Text] [Related]

  • 15. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P, Grifantini M.
    Curr Med Chem; 1999 Jul 18; 6(7):599-614. PubMed ID: 10390603
    [Abstract] [Full Text] [Related]

  • 16. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN, Zhen W, Gharehbaghi K.
    Cancer Res; 1993 May 15; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [Abstract] [Full Text] [Related]

  • 17. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN, Cooney DA, Grusch M, Krupitza G.
    Curr Med Chem; 1999 Jul 15; 6(7):561-74. PubMed ID: 10390601
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.